A federal judge decided that top drug manufacturers must face a class-action lawsuit from consumers who claim they were overcharged for prescription medication. Johnson & Johnson, Bristol-Myers Squibb Co., AstraZeneca Plc and GlaxoSmithKline Plc have all been named as defendants. Drug companies set prices based on the Average Wholesale Price formula, which is used to reimburse federal health programs. Plaintiffs argue that prices were artificially inflated to charge patients more than the AWP.
To read more, go to : J&J, AstraZeneca, Bristol and Glaxo to Face Class Action Suit
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.